Interstitial Lung Disease Program, National Jewish Medical and Research Center, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado, USA The diagnosis and management of SVV remains one of the most challenging clinical scenarios encountered by a clinician. Careful attention to detail and a thorough knowledge of the specific disorders, their therapies, and complications thereof is required to optimally care for these patients. The recent completion of a number of randomized, controlled, multicenter clinical trials has greatly improved our knowledge base and ability to care for vasculitis patient. The next decade holds even more promise.
1. Cotch MF , Hoffman GS , Yerg DE , Kaufman GI , Targonski P , Kaslow RA . The epidemiology of Wegener's granulomatosis:estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population based data sources .Arthritis Rheum1996; 39: 87-92 .
2.
2. Watts RA , Lane SE , Bentham G , Scott DG . Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom . Arthritis Rheum2000; 43: 414-419 .
3.
3. Abdou NI , Kullman GJ , Hoffman GS et al. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s . J Rheumatol2002; 29: 309-316 .
4.
4. Jennette JC , Falk RJ , Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference .Arthritis Rheum1994; 37: 187-192 .
5.
5. Jennette JC , Falk RJ . Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies?Clin Exp Immunol1995; 101(Suppl 1): 18-22 .
6.
6. Jennette JC , Falk R , Andrassay K et al. Nomenclature of systemic vasculitides . Arthritis Rheum1990; 37: 187-192 .
7.
7. Rao JK , Allen NB , Pincus T . Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis . Ann Intern Med1998; 129: 345-352 .
8.
8. Sorensen SF , Slot O , Tvede N , Petersen J.A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature . Ann Rheum Dis2000; 59: 478-482 .
9.
9. Zamora MR , Warner ML , Tuder R , Schwarz MI . Diffuse alveolar hemorrhage and systemic lupus erthematosus (SLE): clinical presentation, histology, survival and outcome . Medicine1997; 76: 192-202 .
11. Couser WG . Glomerulonephritis . Lancet1999; 353: 1509-1515 .
12.
12. Madaio MP , Harrington JT . The diagnosis of glomerular diseases . Arch Intern Med2001; 161: 25-34 .
13.
13. Niles JL , Bottinger EP , Saurina GR et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition .Arch Intern Med1996; 156: 440-445 .
14.
14. Saxena R , Bygren P , Arvastsin B , Wieslander J . Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome . J Intern Med1995; 238: 143-152 .
15.
15. Jayne DR . Pulmonary-renal syndrome . Semin in Respir and Crit Care Med1998; 19: 69-77 .
16.
16. Cordier J-F , Valeyre D , Guillevin L , Loire R , Crechot J-M . Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases . Chest1990; 97: 906-912 .
17.
17. Reuter M , Schnabel A , Wesner F et al. Pulmonary Wegener' sgranulomatosis: correlation between high-resolution CT findings and clinical scoring of disease activity . Chest1998; 114: 500-506 .
18.
18. Frankel SK , Sullivan EJ , Brown KK . Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis . Crit Care Clin2002; 18: 855-879 .
19.
19. Hoffman GS , Kerr GS , Leavitt RY et al. Wegener's granulomatosis:an analysis of 158 patients . Ann Intern Med1992; 116: 488-498 .
20.
20. Swerlick RA , Lawley TJ . Cutaneous vasculitis: its relationship to systemic disease . Med Clin North Am1989; 73: 1221-1235 .
21.
21. Moore PM , Fauci AS . Neurologic manifestations of systemic vasculitis . Am J Med1981; 71: 517-524 .
22.
22. Guillevin L , Lhote F , Gherardi R . Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment . Neurol Clin1997; 15: 865-886 .
23.
23. Moore PM , Calabrese LH . Neurologic manifestations of systemic vasculitides . Semin Neurol1994; 14: 300-306 .
24.
24. Moore PM . Vasculitis of the central nervous system . Semin Neurol1994; 14: 307-312 .
26. Cohen-Tervaert JW , van der Woude FJ , Fauci AS et al. Associationbetween active Wegener's granulomatosis and anticytoplasmic antibodies . Arch Intern Med1989; 149: 2461-2465 .
27.
27. Falk RJ , Jennette JC . Anti-neutorphil cytoplasmic autoantibodies with specificity from myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis . NEJM1988; 325: 1651-1657 .
28.
28. Halbwachs-Mecarelli L , Nusbaum P , Noel LH , Remaux D , Erlinger S . Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis . Clin Exp Immunol1992; 90: 79-84 .
29.
29. van der Woude FJ . Taking anti-neutrophil cytoplasmic antibody (ANCA)testing beyond the limits . Nephrol Dial Transplant2002; 17: 2081-2083 .
30.
30. Stone JH , Talor M , Stebbing J et al. Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions . Arthritis Care Res2000;13: 424-434 .
31.
31. Mandl LA , Solomon DH , Smith EL , Lew RA , Katz JN , Shmerling RH . Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis . Arch Intern Med2002; 162: 1509-1514 .
32.
32. Hagen EC , Daha MR , Hermans J et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization . Kidney Int1998; 53: 743-753 .
33.
33. Choi HK , Liu S , Merkel PA , Colditz GA , Niles JL . Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides:metaanalysis with a focus on myeloperoxidase antibodies . J Rheumatol2001; 28: 1584-1590 .
34.
34. Russell KA , Wiegert E , Schroeder ER , Homburger HA , Specks U.Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions . Clin Immunol2002; 103: 196-203 .
35.
35. Devaney KO , Travis WD , Hoffman G , Leavitt R , Lebovics R , Fauci AS . Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients . Am J Surg Pathol1990; 14: 555-564 .
36.
36. Haas M , Spargo BH , Wit EJ , Meehan SM . Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases . Am J Kidney Dis2000; 35: 433-447 .
37.
37. Jennette JC , Falk RJ . The pathology of vasculitis involving the kidney . Am J Kidney Dis1994; 24: 130-141 .
38.
38. Weiss MA , Crissman JD . Segmental necrotizing glomerulonephritis:diagnostic, prognostic, and therapeutic significance . Am J Kidney Dis1985; 6: 199-211 .
39.
39. Hauer HA , Bajema IM , van Houwelingen HC et al. Renal histology inANCA-associated vasculitis: differences between diagnostic and serologic subgroups . Kidney Int2002; 61: 80-89 .
40.
40. Schnabel A , Holl-Ulrich K , Dalhoff K , Reuter M , Gross WL . Efficacy of transbronchial biopsy in pulmonary vasculitides . Eur Respir J1997;10: 2738-2743 .
41.
41. Specks U.Pulmonary vasculitis. In Schwarz MI , King TE , eds. Intersitial lung disease, third edition, Hamilton: B.C. Decker ; 1998,507-534.
42.
42. Langford CA . Treatment of ANCA-associated vasculitis . N Engl J Med2003; 349: 3-4 .
43.
43. Jayne D , Rasmussen N , Andrassy K et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies . N Engl J Med2003; 349: 36-44 .
48. Aasarod K , Iversen BM , Hammerstrom J , Bostad L , Vatten L , Jorstad S.Wegener's granulomatosis: clinical course in 108 patients with renal involvement . Nephrol Dial Transplant2000; 15: 611-618 .
49.
49. Reinhold-Keller E , Beuge N , Latza U et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis .Arthritis Rheum2000; 43: 1021-1032 .
50.
50. Koldingsnes W , Nossent H . Predictors of survival and organ damage in Wegener's granulomatosis . Rhematology2002; 41: 572-581 .
51.
51. Luqmani RA , Bacon PA , Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis . Q J. Med1994; 87: 671-678 .
52.
52. Guillevin L , Lhote F , Gayraud M et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients . Medicine1996; 75: 17-28 .
53.
53. Hogan SL , Nachman PH , Wilkman AS , Jennette JC , Falk RJ . Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis . J Am Soc Nephrol1996; 7: 23-32 .
54.
54. De'Oliviera J , Gaskin G , Dash A , Rees AJ , Pusey CD . Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis . Am J Kidney Dis1995; 25: 380-389 .
55.
55. Mahr A , Girard T , Agher R , Guillevin L . Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up . Rhematology2001; 40: 492-498 .
56.
56. Koldingsnes W , Nossent JC . Baseline features and initial treatment as predictors of remission and relpase in Wegener's granulomatosis . J Rheumatol2003; 30: 80-88 .
57.
57. www.vasculitis.org. In EUVAS Study Group; 2004.
58.
58. Langford CA , Talar-Williams C , Sneller MC . Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Longterm renal outcome in patients with glomerulonephritis . Arthritis Rheum2000; 43: 1836-1840 .
59.
59. de Groot K , Muhler M , Reinhold-Keller E , Paulsen J , Gross WL . Induction of remission in Wegener's granulomatosis with low dose methotrexate . J Rheumatol1998; 25: 492-495 .
60.
60. Stone JH , Tun W , Hellman DB . Treatment of non-life threateningWegener's granulomatosis with methotrexate and daily prednisone as the initial the rpy of choice . J Rheumatol1999; 26: 1134-1139 .
61.
61. Fauci AS , Haynes BF , Katz P , Wolff SM . Wegener's granulomatosis:propsective clinical and therapeutic expeience with 85 patients for 21 years . Ann Intern Med1983; 98: 76-85 .
62.
62. Hoffman GS , Leavitt RY , Fleisher TA , Minor JR , Fauci AS . Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide . Am J Med1990; 89: 399-402 .
63.
63. de Groot K , Adu D , Savage CO . The value of pulse cyclophosphamidein ANCA-associated vasculitis: meta-analysis and critical review . Nephrol Dial Transplant2001; 16: 2018-2027 .
64.
64. Pusey CD , Rees AJ , Evans DJ , Peters DK , Lockwood CM . Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies . Kidney Int1991; 40: 757-763 .
65.
65. Guillevin L , Lhote F , Cohen P et al. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients .Arthritis Rheum1995; 38: 1638-1645 .
66.
66. Gaskin G , Pusey C . Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis . TherApher2001; 5: 176-181 .
67.
67. Frasca GM , Soverini ML , Falaschini A , Tampieri E , Vangelista A , Stefoni S . Plasma exchange treatment improves prognosis of antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis: a case-control study in 26 patients from a single center . Therap Apher Dial2003; 7: 540-546 .
68.
68. Bosch X , Font J , Mirapeix E , Revert L , Ingelmo M , Urbano-Marquez A . Antimyeloperoxidase autoantibody-associated necrotizing alveolar capillaritis . Am Rev Respir Dis1992; 146: 1326-1329 .
69.
69. Schmitt WH , Hagen EC , Neumann I , Nowack R , Flores-Suarez LF , van der Woude FJ . Treatment of refractory Wegeners granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients . Kidney Int2004; 65: 1440-1448 .
70.
70. Stone JH , Uhlfelder ML , Hellmann DB , Crook S , Bedocs NM , Hoffinan GS . Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety . Arthritis Rheum2001; 44: 1149-1154 .
71.
71. Lamprecht P , Voswinkel J , Lilienthal T et al. Effectiveness of TNF-ablockade with infliximab in refractory Wegener's granulomatosis . Rheumatology2002; 41: 1303-1307 .
72.
72. Bartolucci P , Ramanoelina J , Cohen P et al. Efficacy of the anti-TNFalpha antibody infliximab against refractory systemic vascuiltides: an open pilot study on 10 patients . Rhematology2002; 41: 1126-1132 .
73.
73. Levy Y , George J , Fabbrizzi F , Rotman P , Paz Y , Shoenfeld Y . Marked improvement of Churg-Strauss vasculitis with intravenous gamma globulins . South Med J1999; 92: 412-414 .
74.
74. Jordan SC . Treatment of systemic and renal-limited vasculitic disorders with pooled human intravenous immune globulin . J Clin Immunol1995; 15(Suppl 6): 76S-85S .
75.
75. Jayne DR , Chapel H , Adu D et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity . Q J Med2000; 93: 433-439 .
76.
76. Jayne D . Update on the European Vasculitis Study Group trials . Curr Opin Rheumatol2001; 13: 48-55 .
77.
77. Specks U , Fervenza FC , McDonald TJ , Hogan MC . Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy . Arthritis Rheum2001; 44: 2836-2840 .
78.
78. Reinhold-Keller E , Fink CO , Herlyn K , Gross WL , de Groot K . High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance remission with low-dose methotrexate . Arthritis Rheum2002; 47: 326-332 .
79.
79. Haubitz M , de Groot K . Tolerance of mycophenolate mofetil in end stage renal disease patients with ANCA-associated vasculitis . Clin Nephrol2002; 57: 421-424 .
80.
80. Nowack R , Gobel U , Klooker P , Hergesell O , Andrassy K , van der Woude FJ . Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement . JAm Soc Nephrol1999; 10: 1965-1971 .
81.
81. Metzler C , Fink C , Lamprecht P , Gross WL , Reinhold-Keller E. Maintenance of remission with leflunomide in Wegener's granulomatosis . Rhematology (Oxford)2004; 43: 315-320 .
82.
82. Hoffman GS , Leavitt RY , Kerr GS , Fauci AS . The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate . Arthritis Rheum1992; 35: 1322-1329 .
83.
83. Sneller MC , Hoffman GS , Talar-Williams C , Kerr GS , Hallahan CW , Fauci AS . An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone . Arthritis Rheum1995; 38: 608-613 .
84.
84. Wegener's Granulomatosis Etanercept Trail (WGET) Research Group . Etanercept plus standard therapy for Wegener' granulomatosis .N Engl J Med2005; 352: 351-361 .
85.
85. Ohtake T , Kobayashi S , Honjou Y et al. Generalized Wegener's granulomatosis responding to sulfamethoxazole-trimethoprim monotherapy . Intern Med2001; 40: 666-670 .
86.
86. Stegeman CA , Tervaert JW , Sluiter WJ , Manson WL , de Jong PE , Kallenberg CG . Association of chronic nasal carriage of Staphylo coccus aureus and higher relapse rates in Wegener granulomatosis . Ann Intern Med1994; 120: 12-17 .
87.
87. Stegeman CA , Tervaert JW , de Jong PE , Kallenberg CGM . Trimethoprim-sulfamethoxazole for the prevention of relapses of Wegener's granulomatosis . N Engl J Med1996; 335: 16-20 .
88.
88. Leavitt RY , Hoffman GS , Fauci AS . Response: the role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis . Arthritis Rheum1988; 31: 1073-1074 .
89.
89. Reinhold-Keller E , de Groot K , Rudert H , Nolle B , Heller M , Gross VVL . Response to trimethoprim/sulfamethoxazole in Wegener's granuloma tosis depends on the phase of the disease . Q J Med1996; 89: 15-23 .
90.
90. Gordon M , Luqmani RA , Adu D et al. Relapses in patients with a systemic vasculitis . Q J Med1993; 86: 779-789 .
91.
91. Gayraud M , Guillevin L , le Toumelin P et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients . Arthritis Rheum2001; 44: 666-675 .
92.
92. Kerr GS , Fleisher TA , Hallahan CW , Leavitt RY , Fauci AS , Hoffman GS . Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis . Adv Exp Med Biol1993; 336: 411-414 .
93.
93. Girard T , Mahr A , Noel LH et al. Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study . Rheumatology (Oxford)2001; 40: 147-151 .
94.
94. Matteson EL , Gold KN , Bloch DA , Hunder GG . Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's granulomatosis criteria cohort . Am J Med1996; 101: 129-134 .
95.
95. Romas E , Murphy BF , d'Apice AJ , Kennedy JT , Niall JF . Wegener's granulomatosis: clinical features and prognosis in 37 patients . Aust NZ J Med1993; 23: 168-175 .
97. Stuck AE , Minder CE , Frey FJ . Risk of infectious complications in patients taking glucocorticoids . Rev Infect Dis1989; 11: 954-963 .
98.
98. Adu D , Howie AJ , Scott DG , Bacon PA , McGonigle RJ , Micheal J . Polyarteritis and the kidney . Q J Med1987; 62: 221-237 .
99.
99. Guillevin L , Cohen P , Gayraud M , Lhote F , Jarrousse B , Casassus P . Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients . Medicine1999; 78: 26-37 .
100.
100. Solans R , Bosch JA , Perez-Bocanegra C et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients . Rheumatology2001; 40: 763-771 .
101.
101. Anderson G , Coles ET , Crane M et al. Wegener's granulomatosis: a series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee . Q J Med1992; 83: 427-438 .
102.
102. Guillevin L , Durand-Gasselin B , Cevallos R et al. Microscopic polyangiitis . Arthritis Rheum1999; 42: 421-430 .
103.
103. Lanham J , Elkon K , Pusey C , Hughes G . Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome . Medicine1984; 63: 65-81 .
104.
104. Guillevin L , Guittard T , Bletry Ox , Godeau P , Rosenthal P . Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases . Lung1987; 165: 165-172 .
105.
105. Lhote F , Guillevin L . Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome . Semin in Respir and Crit Care Med1998; 19: 27-45 .
106.
106. Savage CO , Winearls CG , Evans DJ , Rees AJ , Lockwood CM . Microscopic polyarteritis: presentation, pathology and prognosis . Q J Med1985; 56: 467-483 .
107.
107. Aasarod K , Bostad L , Hammerstrom J , Jorstad S , Iversen BM . Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis . Nephrol Dial Transplant2001; 16: 953-960 .
108.
108. Ara J , Mirapeix E , Rodriguez R , Saurina A , Darnell A . Relationship between ANCA and disease activity in small vessel vasculitis patients with anti-MPO ANCA . Nephrol Dial Transplant1999; 14: 1667-1672 .
109.
109. Cohen P , Guillevin L , Baril L , Lhote F , Noel LH , Lesavre P Persistenceof antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients . Clin Exp Rheumatol1995; 13: 193-198 .
110.
110. Cohen Tervaert JW , Goldschmeding R , Elema JD et al. Association of autoantibodies to myeloperoxidase with different forms of vasculitis . Arthritis Rheum1990; 33: 1264-1272 .
111.
111. Cohen-Tervaert JW , Goldschmeding R , Elema JD , Von dem Borne AE , Kallenberg CG . Antimyeloperoxidase antibodies in the Churg-Strauss syndrome . Thorax1991; 46: 70-71 .
112.
112. Gaskin G , Savage CO , Ryan JJ et al. Anti-neutrophil cytoplasmicantibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis . Nephrol Dial Transplant1991; 6: 689-694 .
113.
113. Gross WL . Antineutrophil cytoplasmic autoantibody testing in vasculitides . Rheum Dis Clin North Am1995; 21: 987-1011 .
114.
114. Guillevin L , Visser H , Noel LH et al. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitisB virus infection and Churg-Strauss syndrome-62 patients . J Rheumatol1993; 20: 1345-1349 .
115.
115. Noille B , Specks U , Ludemann J , Rohrbach MS , DeRemee RA , Gross WL . Anticytoplasmic autoantibodies: their immuno diagnostic value in Wegener granulomatosis . Ann Intern Med1989; 111: 28-40 .
116.
116. Schonermarck U , Lamprecht P , Csernok E , Gross WL . Prevalence and spectrum of rheumatic diseases associated with proteinase-3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase ANCA . Rhematology2001; 40: 178-184 .
117.
117. Specks U , Homburger HA . Anti-neutrophil cytoplasmic antibodies . Mayo Clin Proc1994; 69: 1197-1198 .
118.
118. Savige J , Gillis D , Benson E et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA) . Am J Clin Pathol1999; 111: 507-513 .
119.
119. Tesar V , Rihova Z , Jancova E et al. Current treatment strategies in ANCA-positive renal vaculitis lessons from European randomized trials . Nephrol Dial Transplant2003; 18(Suppl 5): v2-v4 .
120.
120. Schmitt WH , Hagen EC , Neumann I et al. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients . Kidney Int2004; 65: 1440-1448 .
121.
121. Langford CA , Sneller MC . Biologic therapies in the vasculitides . Curr Opin Rheumatol2003; 15: 3-10 .
